The Supreme Court is set to hear a case on Monday that raises critical issues regarding the separation of powers within the U.S. government, potentially impacting healthcare coverage under the Affordable Care Act (ACA). This case challenges the constitutionality of a specific section within the Department of Health and Human Services (HHS), which pertains to preventive-care coverage.
Under the ACA, insurers and group health plans are mandated to offer preventive health services without additional costs to patients. However, the law delegates the determination of the specific services to be covered to the U.S. Preventive Services Task Force, an independent panel of experts. This panel, known for recommending various preventive-care services, is integral to the ongoing legal debate.
The core of the dispute hinges on pre-exposure prophylaxis (PrEP), a medication effective in preventing HIV, which the task force recommended as a mandatory service in 2019. The challenge arises from four individuals and two small businesses led by Braidwood Management, who have religious objections to the PrEP coverage, arguing it promotes behaviors contrary to their beliefs.
In 2020, these plaintiffs filed a lawsuit alleging that the task force’s structure violates the Constitution’s appointments clause, which they argue requires that “principal officers” be appointed by the president and confirmed by the Senate. The federal courts are divided on the issue. While U.S. District Judge Reed O’Connor invalidated requirements imposed by the task force since the ACA’s enactment, the U.S. Court of Appeals for the 5th Circuit offered a more limited ruling, applying the decision solely to the challengers.
The Biden administration has brought the matter before the Supreme Court, seeking to clarify the status of the task force. The administration defends the task force members as “inferior officers,” appointed by the HHS Secretary and not requiring Senate confirmation. Instead, this approach purports control by the HHS Secretary, thereby maintaining a supervisory chain accountable to the President, as explained in detail in the SCOTUSblog article.
Opponents, however, argue that the task force members are, in fact, “principal officers” due to their level of independence and argue the need for Senate confirmation. Braidwood Management asserts that their decisions are beyond review by other authorities, thus meriting the principal officer status.
Amicus briefs in support of the government highlight the potential public health implications of a ruling against the task force. For instance, the American Hospital Association emphasized that requiring patients to bear costs for preventive services may deter them from accessing necessary healthcare, potentially reversing significant progress in public health outcomes. Concerns are echoed by HIV, AIDS, and cancer advocacy groups, warning of regressive impacts on current health metrics.
Those supporting Braidwood’s stance argue that insurers might naturally cover cost-effective preventive services without a task force directive. They also propose that adapting the nomination process for task force members to include Senate confirmation could resolve the constitutional issue.
An expected decision, due by June or July, will provide crucial clarifications on the task force’s standing under the ACA and may have lasting effects on the structure of healthcare coverage and federal administrative law.